Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.The company's platform uses biological datasets, human genetics, and programmable biology to power target discovery and development, enabling scientists to systematically generate, interrogate, and prioritize high-confidence therapeutic hypotheses.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 9, 2020 | Series A | $17M | 1 | Ionis Pharmaceuticals | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Ionis Pharmaceuticals | Yes | Series A |